Deep Track Capital
Latest statistics and disclosures from Deep Track Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are XBI, IMVT, GH, GPCR, TARS, and represent 41.55% of Deep Track Capital's stock portfolio.
- Added to shares of these 10 stocks: XBI (+$1.2B), VERA (+$143M), BMRN (+$135M), GRAL (+$88M), MLTX (+$61M), ALKS (+$56M), CRMD (+$56M), CNTA (+$50M), SLNO (+$46M), PCVX (+$46M).
- Started 17 new stock positions in BLLN, ANL, MNPR, IVA, XBI, VSTM, Atai Life Sciences Nv, GRAL, JANX, ALKS. MLTX, CNTA, BHVN, VERA, ENTA, COGT, SLNO.
- Reduced shares in these 10 stocks: TERN (-$272M), AKRO (-$190M), IONS (-$167M), GH (-$138M), ETNB (-$138M), PTGX (-$114M), VRDN (-$89M), CYTK (-$61M), , OCUL (-$47M).
- Sold out of its positions in ACAD, JBIO, AKRO, AUTL, AVTX, CDTX, ETNB, CLYM, EXAS, GMAB. IMA, OLMA, PEPG, PTGX, XNCR, GHRS, ZURA, QURE.
- Deep Track Capital was a net buyer of stock by $656M.
- Deep Track Capital has $5.6B in assets under management (AUM), dropping by 56.53%.
- Central Index Key (CIK): 0001856083
Tip: Access up to 7 years of quarterly data
Positions held by Deep Track Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Deep Track Capital
Deep Track Capital holds 55 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Spdr Series Trust State Street Spd Put Option (XBI) | 21.7 | $1.2B | NEW | 10M | 121.93 |
|
| Immunovant (IMVT) | 5.2 | $293M | +18% | 12M | 25.42 |
|
| Guardant Health (GH) | 5.1 | $286M | -32% | 2.8M | 102.14 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 5.1 | $286M | -2% | 4.1M | 69.55 |
|
| Tarsus Pharmaceuticals (TARS) | 4.4 | $246M | 3.0M | 81.88 |
|
|
| Dynavax Technologies Corp Com New (DVAX) | 4.3 | $242M | 16M | 15.38 |
|
|
| Cytokinetics Com New (CYTK) | 3.8 | $212M | -22% | 3.3M | 63.54 |
|
| Axsome Therapeutics (AXSM) | 3.7 | $210M | +27% | 1.2M | 182.64 |
|
| Apellis Pharmaceuticals (APLS) | 3.5 | $195M | -3% | 7.8M | 25.12 |
|
| Vaxcyte (PCVX) | 3.3 | $185M | +33% | 4.0M | 46.14 |
|
| Maze Therapeatics (MAZE) | 3.1 | $176M | +7% | 4.2M | 41.43 |
|
| Vera Therapeutics Cl A (VERA) | 2.5 | $143M | NEW | 2.8M | 50.64 |
|
| BioMarin Pharmaceutical (BMRN) | 2.4 | $137M | +9153% | 2.3M | 59.43 |
|
| Ionis Pharmaceuticals (IONS) | 2.4 | $135M | -55% | 1.7M | 79.11 |
|
| Nurix Therapeutics (NRIX) | 2.4 | $134M | +16% | 7.0M | 18.97 |
|
| Mbx Biosciences (MBX) | 1.8 | $103M | +3% | 3.2M | 31.54 |
|
| Ocular Therapeutix (OCUL) | 1.7 | $98M | -32% | 8.1M | 12.14 |
|
| Grail (GRAL) | 1.6 | $88M | NEW | 1.0M | 85.59 |
|
| Miragen Therapeutics (VRDN) | 1.4 | $79M | -53% | 2.5M | 31.12 |
|
| Lb Pharmaceuticals Com Shs (LBRX) | 1.3 | $75M | 3.4M | 22.26 |
|
|
| Immunocore Hldgs Ads (IMCR) | 1.2 | $70M | +11% | 2.0M | 34.71 |
|
| Oruka Therapeutics (ORKA) | 1.2 | $66M | -18% | 2.2M | 30.31 |
|
| Bridgebio Pharma (BBIO) | 1.1 | $62M | -32% | 810k | 76.49 |
|
| Cormedix Inc cormedix (CRMD) | 1.1 | $61M | +954% | 5.3M | 11.63 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.1 | $61M | NEW | 4.6M | 13.18 |
|
| Alkermes SHS (ALKS) | 1.0 | $56M | NEW | 2.0M | 27.98 |
|
| Dyne Therapeutics (DYN) | 0.9 | $52M | +32% | 2.7M | 19.56 |
|
| Celldex Therapeutics Com New (CLDX) | 0.9 | $52M | -4% | 1.9M | 27.16 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.9 | $51M | -6% | 7.3M | 6.90 |
|
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.9 | $50M | NEW | 2.0M | 25.01 |
|
| Soleno Therapeutics (SLNO) | 0.8 | $46M | NEW | 1.0M | 46.30 |
|
| Verastem Com New (VSTM) | 0.8 | $44M | NEW | 5.7M | 7.72 |
|
| Bicara Therapeutics (BCAX) | 0.8 | $44M | +7% | 2.6M | 16.83 |
|
| Geron Corporation (GERN) | 0.8 | $43M | -20% | 33M | 1.32 |
|
| Engene Holdings (ENGN) | 0.7 | $40M | +95% | 4.4M | 9.03 |
|
| Biosante Pharmaceuticals (ANIP) | 0.7 | $38M | +6% | 478k | 78.94 |
|
| Terns Pharmaceuticals (TERN) | 0.6 | $31M | -89% | 769k | 40.40 |
|
| Enanta Pharmaceuticals (ENTA) | 0.6 | $31M | NEW | 2.0M | 15.77 |
|
| Mind Medicine Mindmed Com New (MNMD) | 0.4 | $22M | +11% | 1.7M | 13.39 |
|
| Tango Therapeutics (TNGX) | 0.4 | $22M | +68% | 2.5M | 8.86 |
|
| X4 Pharmaceuticals Com New (XFOR) | 0.4 | $20M | +346% | 5.0M | 4.00 |
|
| Atai Beckley Nv SHS | 0.3 | $19M | NEW | 4.7M | 4.09 |
|
| Xenon Pharmaceuticals (XENE) | 0.3 | $16M | -69% | 366k | 44.82 |
|
| Cogent Biosciences (COGT) | 0.3 | $16M | NEW | 453k | 35.52 |
|
| Cybin Com New (HELP) | 0.3 | $15M | +85% | 1.9M | 8.18 |
|
| Context Therapeutics (CNTX) | 0.2 | $11M | 7.4M | 1.47 |
|
|
| Monopar Therapeutics Com New (MNPR) | 0.1 | $6.2M | NEW | 95k | 65.30 |
|
| Biohaven Call Option (BHVN) | 0.1 | $5.6M | NEW | 500k | 11.29 |
|
| Crescent Biopharma (CBIO) | 0.1 | $5.4M | 454k | 11.86 |
|
|
| Aligos Therapeutics Com New (ALGS) | 0.1 | $4.1M | 444k | 9.32 |
|
|
| Billiontoone Cl A (BLLN) | 0.1 | $4.1M | NEW | 50k | 81.84 |
|
| Rapt Therapeutics Com New (RAPT) | 0.1 | $3.7M | -85% | 110k | 33.87 |
|
| Inventiva Sa Ads (IVA) | 0.0 | $2.3M | NEW | 490k | 4.65 |
|
| Janux Therapeutics (JANX) | 0.0 | $1.2M | NEW | 90k | 13.80 |
|
| Adlai Nortye Sponsored Ads (ANL) | 0.0 | $50k | NEW | 35k | 1.42 |
|
Past Filings by Deep Track Capital
SEC 13F filings are viewable for Deep Track Capital going back to 2021
- Deep Track Capital 2025 Q4 filed Feb. 13, 2026
- Deep Track Capital 2025 Q3 filed Nov. 14, 2025
- Deep Track Capital 2025 Q2 filed Aug. 14, 2025
- Deep Track Capital 2025 Q1 filed May 15, 2025
- Deep Track Capital 2024 Q4 filed Feb. 14, 2025
- Deep Track Capital 2024 Q3 filed Nov. 14, 2024
- Deep Track Capital 2024 Q2 filed Aug. 14, 2024
- Deep Track Capital 2024 Q1 filed May 15, 2024
- Deep Track Capital 2023 Q4 filed Feb. 14, 2024
- Deep Track Capital 2023 Q3 filed Nov. 14, 2023
- Deep Track Capital 2023 Q2 restated filed Sept. 6, 2023
- Deep Track Capital 2023 Q2 filed Aug. 14, 2023
- Deep Track Capital 2023 Q1 filed May 15, 2023
- Deep Track Capital 2022 Q4 filed Feb. 14, 2023
- Deep Track Capital 2022 Q3 filed Nov. 14, 2022
- Deep Track Capital 2022 Q2 filed Aug. 12, 2022